Dialogue Health Technologies (TSE:CARE) PT Lowered to C$6.25 – MarketBeat
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Dialogue Health Technologies (TSE:CARE – Get Rating) had its target price dropped by stock analysts at National Bankshares from C$6.75 to C$6.25 in a note issued to investors on Thursday, BayStreet.CA reports. The brokerage currently has an “outperform” rating on the stock. National Bankshares’ target price indicates a potential upside of 174.12% from the company’s current price.
A number of other brokerages have also recently issued reports on CARE. Royal Bank of Canada lowered their target price on shares of Dialogue Health Technologies from C$6.00 to C$5.00 and set a “sector perform” rating on the stock in a report on Friday, September 23rd. TD Securities lowered their target price on shares of Dialogue Health Technologies from C$3.50 to C$2.50 and set a “hold” rating on the stock in a report on Thursday. Scotiabank lowered their target price on shares of Dialogue Health Technologies from C$8.00 to C$5.50 in a report on Wednesday, November 16th. CIBC decreased their price target on shares of Dialogue Health Technologies from C$4.00 to C$3.50 and set a “neutral” rating on the stock in a report on Wednesday, October 12th. Finally, Canaccord Genuity Group decreased their price target on shares of Dialogue Health Technologies from C$6.00 to C$5.00 in a report on Wednesday, November 16th.
Dialogue Health Technologies Stock Performance
TSE:CARE traded up C$0.11 during trading hours on Thursday, reaching C$2.28. The stock had a trading volume of 15,404 shares, compared to its average volume of 53,069. The company has a debt-to-equity ratio of 2.54, a quick ratio of 3.85 and a current ratio of 4.00. The stock has a 50 day simple moving average of C$2.68 and a 200 day simple moving average of C$2.84. Dialogue Health Technologies has a 12-month low of C$2.05 and a 12-month high of C$7.39. The stock has a market cap of C$151.26 million and a P/E ratio of 6.51.
About Dialogue Health Technologies
(Get Rating)
Dialogue Health Technologies Inc operates a digital healthcare and wellness platform in Canada Germany, and Australia. Its Integrated Health Platform is a healthcare hub that centralizes its programs in a single user-friendly application, which provide access to psychologists, psychotherapists, social workers, physicians, nurses, and health specialists.
Featured Articles
- Cal-Maine Posts Record Quarter, Remain CALM Income Investors
- Tesla Stock: What the Bulls and the Bears Are Getting Wrong
- Big Health Care Stocks to Watch in the New Year
- The Top Three Stocks Analysts Say To Buy
- Can Dick’s Sporting Goods Stock Score Another Win In Q4?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Dialogue Health Technologies, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Dialogue Health Technologies wasn’t on the list.
While Dialogue Health Technologies currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you’ll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Wondering when you’ll finally be able to invest in SpaceX, StarLink or The Boring Company? Enter your email address below to learn when Elon Musk will let these companies finally IPO.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
As Featured By:
326 E 8th St #105, Sioux Falls, SD 57103
contact@marketbeat.com
(844) 978-6257
© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer.